86 related articles for article (PubMed ID: 4095390)
1. [Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
Nomoto S; Inoue K; Horiuchi M; Yokokawa H; Takaba T; Ishii J
Kokyu To Junkan; 1985 Nov; 33(11):1355-60. PubMed ID: 4095390
[No Abstract] [Full Text] [Related]
2. [Importance of the oxygenation of cardioplegic solutions for myocardial protection in cardiac surgery].
Gomes OM
Arq Bras Cardiol; 1984 Dec; 43(6):389-96. PubMed ID: 6537762
[No Abstract] [Full Text] [Related]
3. Calcium and cardioplegia. The optimal calcium content for the St. Thomas' Hospital cardioplegic solution.
Yamamoto F; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1984 Jun; 87(6):908-12. PubMed ID: 6727412
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the protective effects on the ischemic myocardium of coronary perfusion with perfluorochemicals (fluosol-DA)--a comparison with cold blood cardioplegia].
Ishimaru S; Hirayama T; Uchino T; Hakoshima A; Hino H; Yamada M; Koike S; Furukawa K; Takahashi M; Yoshihama I
Nihon Kyobu Geka Gakkai Zasshi; 1986 Jan; 34(1):62-8. PubMed ID: 3711703
[No Abstract] [Full Text] [Related]
5. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
Rousou JH; Dobbs WA; Engelman RM
Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
[TBL] [Abstract][Full Text] [Related]
6. Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig hearts.
Steensrud T; Nordhaug D; Husnes KV; Aghajani E; Sørlie DG
Ann Thorac Surg; 2004 Apr; 77(4):1391-7. PubMed ID: 15063273
[TBL] [Abstract][Full Text] [Related]
7. [Difference of responses to a cardioplegic solution between the immature and the mature myocardium].
Watanabe H; Yokosawa T; Miyamura H; Eguchi S
Kyobu Geka; 1987 Jul; 40(8):615-9. PubMed ID: 3656829
[No Abstract] [Full Text] [Related]
8. The optimal glucose concentration for intermittent cardioplegia in isolated rat heart when added to St. Thomas' Hospital cardioplegic solution.
Owen P; du Toit EF; Opie LH
J Thorac Cardiovasc Surg; 1993 Jun; 105(6):995-1006. PubMed ID: 8501949
[TBL] [Abstract][Full Text] [Related]
9. Use of sodium bicarbonate vials or syringes to buffer cardioplegic solutions.
Miller LG; Gardner SN
Am J Hosp Pharm; 1986 Jun; 43(6):1416, 1420. PubMed ID: 3014873
[No Abstract] [Full Text] [Related]
10. [Important electrophysiological changes, in subjects with implanted pacemakers, occurring during extracorporeal circulation and with a cardioplegic solution. Experimental study in dogs].
Costa R; Pêgo-Fernandes PM; Brito PL; Moreira LF; Stolf NA; Jatene AD; Armelin E
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(3):115-9. PubMed ID: 4095439
[No Abstract] [Full Text] [Related]
11. The St. Thomas' hospital cardioplegic solution: a characterization in two species.
Jynge P; Hearse DJ; Feuvray D; Mahalu W; Canković-Darracott S; O'Brien K; Braimbridge MV
Scand J Thorac Cardiovasc Surg Suppl; 1981; 30():1-28. PubMed ID: 6278581
[TBL] [Abstract][Full Text] [Related]
12. High volume cardioplegia.
Preusse CJ; Schulte HD; Bircks W
Ann Chir Gynaecol; 1987; 76(1):39-45. PubMed ID: 3109306
[No Abstract] [Full Text] [Related]
13. Maintenance of cardiac glutathione levels after cold ischemia.
Magovern JA; Martin LF; Pae WE; Miller CA; Answine J; Grotyohann LW; Scaduto RC
Curr Surg; 1988; 45(1):31-3. PubMed ID: 3345683
[No Abstract] [Full Text] [Related]
14. Effects of halothane on post-cardioplegic functional recovery--the role of cardioplegic solution.
Genade S; Tromp E; Lochner RC; Lochner A
S Afr Med J; 1998 Apr; 88 Suppl 2():C96-8. PubMed ID: 9595004
[No Abstract] [Full Text] [Related]
15. [The efficacy of adding diltiazem to the St. Thomas' Hospital cardioplegic solution in the immature myocardium].
Watanabe H; Yokosawa T; Miyamura H; Eguchi S; Imai S
Rinsho Kyobu Geka; 1988 Oct; 8(5):460-3. PubMed ID: 9301869
[No Abstract] [Full Text] [Related]
16. Improved myocardial protection with perfluorocarbon cardioplegia.
Gardner TJ; Flaherty JT; Kanter KR; Magovern GJ
Prog Clin Biol Res; 1983; 122():405-17. PubMed ID: 6878379
[TBL] [Abstract][Full Text] [Related]
17. eComment: myocardial protection: efficacy of a novel magnesium-basedcardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
Bockeria LA; Movsesyan RR; Ryabtsev DV; Grigoryants TR
Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):749. PubMed ID: 18801803
[No Abstract] [Full Text] [Related]
18. Supraphysiological levels of magnesium in cardioplegic arrest solutions: is there cause for concern?
Tyers GF
Can J Cardiol; 1995 Jan; 11(1):21-2. PubMed ID: 7850660
[No Abstract] [Full Text] [Related]
19. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
[TBL] [Abstract][Full Text] [Related]
20. Protection of the chronic hypoxic immature rat heart during global ischemia.
Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
